GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
6.23
+0.08 (1.30%)
At close: Aug 1, 2025, 4:00 PM
5.82
-0.41 (-6.58%)
After-hours: Aug 1, 2025, 7:47 PM EDT
GlucoTrack Market Cap
GlucoTrack has a market cap or net worth of $3.54 million as of August 1, 2025. Its market cap has decreased by -59.41% in one year.
Market Cap
3.54M
Enterprise Value
-5.30M
1-Year Change
-59.41%
Ranking
Category
Stock Price
$6.23
Market Cap Chart
Since April 25, 2013, GlucoTrack's market cap has decreased from $34.13M to $3.54M, a decrease of -89.64%. That is a compound annual growth rate of -16.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 3.54M | -40.95% |
| Dec 31, 2024 | 5.99M | 9.59% |
| Dec 29, 2023 | 5.46M | -74.96% |
| Dec 30, 2022 | 21.82M | -66.12% |
| Dec 31, 2021 | 64.40M | -9.57% |
| Dec 31, 2020 | 71.22M | -26.72% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 681.91B |
| Johnson & Johnson | 402.75B |
| AbbVie | 334.38B |
| UnitedHealth Group | 240.40B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.48B |
| Novo Nordisk | 221.96B |